Abstract: The disclosure relates to a fifth generation (5G) or sixth generation (6G) communication system for supporting a higher data transfer rate. A method performed by a user equipment in a wireless communication system is provided. The method includes executing an application in the user equipment, identifying a user equipment route selection policy (URSP) rule mapped to the application, based on configuration information on the application, identifying a single-network slice selection assistance information (S-NSSAI) mapped to the application, based on the URSP rule mapped to the application, and transmitting a message requesting registration of the S-NSSAI mapped to the application to a core network via a base station. The S-NSSAI may correspond to a network slice selection assistance information (NSSAI) not allowed by the core network to be registered among NSSAIs configured for the user equipment.

Abstract: The present invention relates to a method and system for training a machine learning model for abnormal behavior recognition.

Abstract: The present invention relates to a method and system for training a machine learning model for medical image classification.

Abstract: The invention provides a radiology report editing method and system.

Abstract: The invention provides a model training method and system that uses pretrained features of a teacher neural network trained on a billion-size dataset to train a student neural network. The model training method leverages the teacher neural network to design a more stable loss function that works well with more sophisticated learning rate schedules to reduce training time and make the augmentation designing process more natural.

Abstract: A labeling apparatus according to an embodiment of the present invention includes a pathological data receiving unit configured to receive pathological data about a patient when a first label is a positive index or an uncertain index in a medical image of the patient which is labeled with the first label, a label input unit configured to receive a second label corresponding to the pathological data, a medical image receiving unit configured to receive a medical image corresponding to the pathological data, and a first processing unit configured to label the received medical image with the positive index and store the medical image labeled with the positive index in a positive data set when the second label is the positive index, and label the received medical image with a negative index and store the medical image labeled with the negative index in a negative data set when the second label is the negative index.

Abstract: Included are methods to make ceramic proppants. The methods comprise coating green proppants with at least one reactive alumina or zirconium agent, such as gamma alumina. Also included are green proppants and liquid-phase sintered proppants made with the use of the reactive agent. Further included are uses for these proppants, such as in the oil and gas recovery areas.

Abstract: A method for autonomous record population with past agricultural treatments, including: monitoring a user device parameter of a user device for a trigger event, wherein the user device is associated with a user account; automatically initiating sensor measurement recordation with a user device in response to occurrence of the trigger event; recording a set of sensor measurements over a treatment time period; automatically identifying a past agricultural treatment based on the sensor measurements; and automatically generating a record of the past agricultural treatment for the user account, the record including: the treatment time period, an identifier for the past agricultural treatment, and a field identifier for the predefined geofence.

Abstract: A method for autonomous record population with past agricultural treatments, including: monitoring a user device parameter of a user device for a trigger event, wherein the user device is associated with a user account; automatically initiating sensor measurement recordation with a user device in response to occurrence of the trigger event; recording a set of sensor measurements over a treatment time period; automatically identifying a past agricultural treatment based on the sensor measurements; and automatically generating a record of the past agricultural treatment for the user account, the record including: the treatment time period, an identifier for the past agricultural treatment, and a field identifier for the predefined geofence.

Abstract: A method for autonomous record population with past agricultural treatments, including: monitoring a user device parameter of a user device for a trigger event, wherein the user device is associated with a user account; automatically initiating sensor measurement recordation with a user device in response to occurrence of the trigger event; recording a set of sensor measurements over a treatment time period; automatically identifying a past agricultural treatment based on the sensor measurements; and automatically generating a record of the past agricultural treatment for the user account, the record including: the treatment time period, an identifier for the past agricultural treatment, and a field identifier for the predefined geofence.

Abstract: An hydraulic actuator with a housing having two ports (A, C) that selectively receive pressured fluid to move a piston (12) to a forward position (12F) or to a rearward position (12R), wherein the piston can be moved to a third, or neutral position (12N) by applying equally pressured fluid to both ports. A pusher (24) that lies in the same housing cavity as the piston, is pushed forward by pressured fluid applied to the second port (C), and the pusher pushes the piston forwardly. The pusher moves forward until the pusher abuts a housing surface (52), at which point the piston lies in the third position (12N).

Abstract: The invention herein relates to a pharmaceutical composition containing loratadine and derivatives thereof which is suitable for use in soft capsule dosage forms. A pharmaceutical composition according to the invention comprises loratadine and derivatives thereof in a pharmaceutically effective amount; and a solvent system comprising a mixture of medium chain fatty acids. The loratadine compositions exhibit good solubility and storage stability while maintaining bioavailability of the drug. The compositions also permit high concentrations of solubilized loratadine per total fill volume and thereby permit the use of smaller capsules to deliver the same dosage of drug.

Abstract: A system and method for alerting a person riding on a vehicle of at least one location along the route of the vehicle is disclosed. The system includes a base station, mounted along a track of a railroad transportation system, wherein the base station emits a signal which contains a unique identification designation for a location along the system. The signal that is emitted by the base station is not detectible when the person riding on the vehicle is not present in the vicinity of the base station. The system also includes a personal electronic device adapted to be carried by the user. The personal electronic device is capable of detecting the unique identification designation being transmitted by the base station.

Abstract: Envelope detector and method for determining whether the level of a differential input signal DPIN?DNIN is above a reference voltage VREF. The differential input signal is converted to a differential current IDP?IDN, the reference voltage is converted to a reference current IREF, the currents are compared to determine if |IDP?IDN| is greater than IREF, and a valid differential signal is indicated when |IDP?IDN| is greater than IREF.

Abstract: Systems and methods of providing mobile network management of assets on a network are presented. In accordance with the method, a network management server is provided to control a network asset on a network. The network asset is connected to the network management server via a connection path. A secure communication path is established between the network management server and a mobile wireless capable device. The network asset is managed via the secure communication path with the mobile wireless capable device. The network is administered via the secure communication path with the mobile wireless capable device.

Abstract: A tape drive having a cartridge receiving area for receiving a cartridge containing a recording medium on a supply reel is disclosed. The tape drive has a take-up reel. The take-up reel includes a take-up rotatably mounted to the tape drive and a pair of flanges mounted on either side of the take-up hub. A magnetic read/write head is disposed between the cartridge receiving area and the take-up reel. A pair of fixed guide assemblies is disposed symmetrically about the magnetic read/write head. Each of the fixed guide assemblies has a fixed guide mount fixed to the tape drive, a fixed guide attached to a top of the fixed guide mount, and a spring/pressure pad having at least one pressure pad mounted to the fixed guide, wherein the pressure pad applies pressure to a top edge of the recording medium when the tape drive is operational. The tape drive also has a forward guide roller and a rearward guide roller disposed symmetrically about the magnetic read/write head.

Abstract: The invention herein relates to a pharmaceutical composition containing loratadine and derivatives thereof which is suitable for use in soft capsule dosage forms. A pharmaceutical composition according to the invention comprises loratadine and derivatives thereof in a pharmaceutically effective amount; and a solvent system comprising a mixture of medium chain fatty acids. The loratadine compositions exhibit good solubility and storage stability while maintaining bioavailability of the drug. The compositions also permit high concentrations of solubilized loratadine per total fill volume and thereby permit the use of smaller capsules to deliver the same dosage of drug.

Abstract: The invention herein relates to a pharmaceutical composition containing loratadine and derivatives thereof which is suitable for use in soft capsule dosage forms. A pharmaceutical composition according to the invention comprises loratadine and derivatives thereof in a pharmaceutically effective amount; and a solvent system comprising a mixture of medium chain fatty acids. The loratadine compositions exhibit good solubility and storage stability while maintaining bioavailability of the drug. The compositions also permit high concentrations of solubilized loratadine per total fill volume and thereby permit the use of smaller capsules to deliver the same dosage of drug.